Image For Activity Cover
GREPNSEM2502 - CME/CMLE - Optimizing Sample Sizes for NSCLC Biomarker Testing
Course Description

Optimizing Sample Sizes for NSCLC Biomarker Testing   

Activity Description: 

This interactive microlearning activity is part of a case-based series designed to engage pathologists, laboratory professionals, and other members of the multidisciplinary cancer care team in improving biomarker testing and treatment for NSCLC. This specific course focuses on optimizing sample sizes for NSCLC biomarker testing and navigating common issues with specimens. 

 

Course topics include:  

  • Optimizing sample sizes 

  • Dealing with inadequate sampling 

  • Best practices in specimen grossing, specimen cutting 

  • Material evaluation and test selection 

Target Audience
This activity has been designed to meet the educational needs of pathologists and laboratory professionals.    


Faculty/Authors
Ying-Chun Lo, M.D., Ph.D.   
Assistant Professor and Consultant, Divisions of Anatomic Pathology and Laboratory Genetics and Genomics
Director, Anatomic Pathology, 
Professor, Pathology, Internal Medicine, and Cardiovascular Medicine
Mayo Clinic, Rochester, MN 

Physician Competencies:  
Patient Care, Medical Knowledge, Practice-Based Learning, and Improvement  

Credit Designation Statement
The ASCP designates this activity for a maximum of .25 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.  

ASCP designates this activity for a maximum of .25 CMLE credit.  This activity meets CMP and state re-licensure requirements for laboratory personnel.  

For questions regarding CME credit, please contact ASCP Customer Service at 1-800-267-2727, option 2, in the US & Canada or internationally at access code + 3-1-312-541-4890. Monday-Friday, 8am-5pm CT. 

Method of Participation
To complete the activity and receive credit, the participant must attend the program. CME certificates will be provided online.  

Commercial Support
This activity is supported by independent educational grants from AstraZeneca Pharmaceuticals and Daiichi Sankyo, Inc. 


Instructions

To claim CME/CMLE credit for the exercise, do the following:

  1. Review the Technical Considerations.
  2. Click Go to Content and click the first module of the course.
  3. Complete the Demographic Survey.
  4. Complete the Pre-Test.
  5. Review the Educational Activity.
  6. Complete and submit the Post Exam. You will have a maximum of three attempts to obtain the required score. You will be notified if you have met the credit requirements after each attempt.
  7. Submit the course Evaluation.
  8. Enter the maximum number of credits offered and click Claim CME/CMLE to register credit.

Faculty Disclosures 

Technical Considerations 

Release Dates: 2/3/2025         
Review Date:
Expiration Date: 2/3/2028    




Course Objectives

Upon completion of this activity, you will be able to:

  • Apply current practice guidelines for biomarker testing in patients with NSCLC 

  • Optimize NSCLC specimen protocols to ensure sufficient sample sizes for biomarker testing 

  • Take a more active role in their institutions to drive appropriate and equitable biomarker testing for patients with NSCLC 

 

 

 

Summary
Availability: On-Demand
Credit Offered:
0.25 CME/CMLE Credit
Powered By